CORT CORCEPT THERAPEUTICS INC
Price Chart
Executive Summary
Corcept Therapeutics' CEO and CDO sold $3.04M in open-market shares within a week of the Q1 earnings release. The trades represent only ~0.05% of market cap and are likely routine portfolio management, not a bearish signal. Q1 revenue grew 4.9% YoY to $164.9M, but the company reported a net loss of $31.8M vs net income of $20.5M in the prior year, driven by increased spending on the Lifyorli launch.
Key Financial Metrics
Actionable Insight
Monitor upcoming Q2 earnings for profitability recovery as guided, and track early Lifyorli sales trajectory. Insider sales are minor and do not warrant action, but any acceleration in selling by C-suite would be a watch item.
Key Facts
- CEO Belanoff sold 40,000 shares at ~$50.10 for $2.00M on May 1, 2026.
- CDO Guyer sold 20,000 shares at ~$51.83 for $1.04M on May 5, 2026 (also exercised options with no cash impact).
- Total insider sales of $3.04M represent ~0.054% of $5.6B market cap.
- Q1 2026 revenue rose 4.9% YoY to $164.9M; net loss of $31.8M vs net income of $20.5M in Q1 2025.
- 2026 revenue guidance raised to $950M-$1,050M; Lifyorli (relacorilant) approved by FDA for ovarian cancer in March 2026.
Financial Impact
Insider selling of $3.04M is negligible relative to $5.6B market cap.
Risk Factors
- Delays in relacorilant NDA for Cushing's syndrome or regulatory setbacks.
- Competition in ovarian cancer and Cushing's syndrome markets.
- Failure to return to profitability as guided in Q2 2026.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CORT-1778185862573 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
8d ago
|
Insider Cluster
| $74.77 awaiting T+1 | awaiting T+1 | — | $82.91 (+10.89%) |
|
Jun 3, 2026
9d ago
|
Insider Cluster
| $74.89 $72.62 | ▼ −3.03% | ▼ −0.43% | $82.91 (+10.71%) |
|
Jun 3, 2026
9d ago
|
Insider Cluster
| $74.89 $72.62 | ▲ +3.03% | ▲ +0.43% | $82.91 (−10.71%) |
|
Jun 3, 2026
9d ago
|
Insider Cluster
| $74.89 $72.62 | ▼ −3.03% | ▼ −0.43% | $82.91 (+10.71%) |
|
Jun 3, 2026
9d ago
|
8-K
| $72.65 $74.89 | ▲ +3.08% | ▲ +2.68% | $82.91 (+14.12%) |
|
Jun 2, 2026
10d ago
|
Insider Cluster
| $72.65 $74.89 | ▲ +3.08% | ▲ +2.68% | $82.91 (+14.12%) |
|
May 29, 2026
14d ago
|
Insider Cluster
| $70.44 $71.20 | ▲ +1.08% | ▲ +0.93% | $82.91 (+17.70%) |
|
May 29, 2026
14d ago
|
Insider Cluster
| $70.44 $71.20 | ▲ +1.08% | ▲ +0.93% | $82.91 (+17.70%) |
|
May 1, 2026
6w ago
|
Insider Cluster
| $51.42 $51.60 | ▲ +0.35% | ▲ +0.69% | $82.91 (+61.24%) |
|
Mar 20, 2026
12w ago
|
Insider Cluster
| $34.64 $33.63 | ▼ −2.92% | ▼ −4.02% | $82.91 (+139.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access